Immunogenic cell death induced by ROS oxidative stress could increase the release of inflammatory cytokines, such as tumor necrosis factor α (TNFα), which could further activate the immune response in vivo to inhibit and eliminate both primary tumor cells and distant sites tumor (or secondary cancer cells) (Fu L. et al., 2021; Huang et al., 2021). The gene discussed is TNF; the disease is cancer.